- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article (WORD)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (45)
- Timeline of Article Publication Processes (9)
- Article Quality Tracking (2)
- Reference Citation Analysis (System.Threading.Tasks.Task`1[System.Int32])
-
Full Article (HTML) (155) -
Full Article (PDF) (56) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3773)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2019 (publication date) through Jun 30, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Choi YI, Chung JW, Park DK, Kim KO, Kwon KA, Kim YJ, Seo JY. Tailored eradication vs empirical bismuth-containing quadruple therapy for first-line Helicobacter pylori eradication: A comparative, open trial. World J Gastroenterol 2019; 25(46): 6743-6751 [PMID: 31857776 DOI: 10.3748/wjg.v25.i46.6743] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i46/6743.htm |
| Number | Citing Articles |
| 1 |
Francis Megraud, Robin Bruyndonckx, Samuel Coenen, Linda Wittkop, Te-Din Huang, Martin Hoebeke, Lucie Bénéjat, Philippe Lehours, Herman Goossens, Youri Glupczynski. Helicobacter pylori resistance to antibiotics in Europe in 2018 and its relationship to antibiotic consumption in the community. Gut 2021; 70(10): 1815 doi: 10.1136/gutjnl-2021-324032
|
| 2 |
Yu Huang, Jinnan Chen, Zhaohui Ding, Xiao Liang, Hong Lu.
Susceptibility testing alone will not reliably achieve high
Helicobacter pylori
cure rates: A systematic review and meta‐analysis
. Journal of Gastroenterology and Hepatology 2022; doi: 10.1111/jgh.15864
|
| 3 |
Biao Guo, Nv-Wei Cao, Hao-Yue Zhou, Xiu-Jie Chu, Bao-Zhu Li. Efficacy and safety of bismuth-containing quadruple treatment and concomitant treatment for first-line Helicobacter pylori eradication: A systematic review and meta-analysis. Microbial Pathogenesis 2021; 152: 104661 doi: 10.1016/j.micpath.2020.104661
|
| 4 |
Anthony O'Connor, Takahisa Furuta, Javier P. Gisbert, Colm O'Morain.
Review – Treatment of
Helicobacter pylori
infection 2020
. Helicobacter 2020; 25(S1) doi: 10.1111/hel.12743
|
| 5 |
Jun-Hyung Cho, So-Young Jin. Current guidelines for <i>Helicobacter pylori </i>treatment in East Asia 2022: Differences among China, Japan, and South Korea. World Journal of Clinical Cases 2022; 10(19): 6349-6359 doi: 10.12998/wjcc.v10.i19.6349
Abstract(23) |
Core Tip(17) |
Full Article(HTML)(94)
|
Full Article (PDF)-1108K(6)
|
Full Article (Word)-436K(1)
|
Audio-1972K(2)
|
Peer-Review Report-290K(2)
|
Answering Reviewers-160K(3)
|
Times Cited (0)
|
Total Visits (345)
|
Open
|
| 6 |
Caiqi Liu, Yuan Wang, Jiaqi Shi, Chunhui Zhang, Jianhua Nie, Shun Li, Tongsen Zheng. The status and progress of first-line treatment against Helicobacter pylori infection: a review. Therapeutic Advances in Gastroenterology 2021; 14: 175628482198917 doi: 10.1177/1756284821989177
|
| 7 |
Hyungchul Park, Jeong Hoon Lee. Recent Trends in Tailored Treatments for Helicobacter pylori Infection. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2021; 21(2): 115 doi: 10.7704/kjhugr.2021.0005
|
| 8 |
Youn I Choi, Jun-Won Chung, Kyoung Oh Kim, Kwang An Kwon, Yoon Jae Kim, Jung Ho Kim, Ja Young Seo, Dong Kyun Park. Tailored eradication strategy <i>vs</i> concomitant therapy for <i>Helicobacter pylori</i> eradication treatment in Korean patients. World Journal of Gastroenterology 2021; 27(31): 5247-5258 doi: 10.3748/wjg.v27.i31.5247
|
| 9 |
Jun-Hyung Cho, So Young Jin, Suyeon Park. Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial. Expert Review of Anti-infective Therapy 2022; 20(6): 923 doi: 10.1080/14787210.2022.2017280
|
| 10 |
Olga P. Nyssen, Marta Espada, Javier P. Gisbert. Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.913436
|
| 11 |
A Reum Choe, Ki-Nam Shim, Yehyun Park, Eun-Mi Song, Chung Hyun Tae, Sung-Ae Jung. Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with Helicobacter pylori Infection. Journal of Clinical Medicine 2021; 10(12): 2619 doi: 10.3390/jcm10122619
|
| 12 |
Javier P. Gisbert. Empirical or susceptibility-guided treatment forHelicobacter pyloriinfection? A comprehensive review. Therapeutic Advances in Gastroenterology 2020; 13: 175628482096873 doi: 10.1177/1756284820968736
|
| 13 |
Erick A. Argueta, Steven F. Moss. Management of Helicobacter pylori. Current Opinion in Gastroenterology 2020; 36(6): 518 doi: 10.1097/MOG.0000000000000678
|
| 14 |
Sang Yoon Kim, Jae Myung Park, Chul-Hyun Lim, Hye Ah Lee, Ga-Yeong Shin, Younghee Choe, Yu Kyung Cho, Myung-Gyu Choi. Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori. Gut and Liver 2021; 15(4): 528 doi: 10.5009/gnl20225
|